Cargando…
Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
Parkinson's disease (PD) is the second most frequent neurodegenerative brain disease (NBD) after Alzheimer's disease (AD). Statins are the most common lipid‐lowering agents used in the management of dyslipidemia and the prevention of primary and secondary cardiovascular diseases (CVD) even...
Autores principales: | Al‐kuraishy, Hayder M., Al‐Gareeb, Ali I., Alexiou, Athanasios, Papadakis, Marios, Alsayegh, Abdulrahman A., Almohmadi, Najlaa Hamed, Saad, Hebatallah M., Batiha, Gaber El‐Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944858/ https://www.ncbi.nlm.nih.gov/pubmed/36811160 http://dx.doi.org/10.1002/prp2.1063 |
Ejemplares similares
-
New insights on the potential effect of vinpocetine in Parkinson’s disease: one of the neglected warden and baffling topics
por: Al-kuraishy, Hayder M., et al.
Publicado: (2023) -
The potential role of scavenger receptor B type I (SR‐BI) in SARS‐CoV‐2 infection
por: Alkazmi, Luay, et al.
Publicado: (2023) -
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
por: Alrouji, Mohammed, et al.
Publicado: (2023) -
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
por: Alrouji, Mohammed, et al.
Publicado: (2023) -
New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects
por: Al‐Kuraishy, Hayder M., et al.
Publicado: (2023)